Nasal Tolerance to Experimental Autoimmune Myasthenia Gravis: Tolerance Reversal by Nasal Administration of Minute Amounts of Interferon-γ
- 30 April 1998
- journal article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 87 (1) , 15-22
- https://doi.org/10.1006/clin.1997.4495
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Oral cytokine administrationImmunology Today, 1996
- Treatment of Autoimmune Disease by Oral Tolerance to AutoantigensClinical Immunology and Immunopathology, 1996
- Expression of RANTES in human airway epithelial cells: effect of corticosteroids and interleukin‐4, ‐10 and ‐13Immunology, 1996
- Mechanisms underlying T-cell toleranceCurrent Opinion in Immunology, 1996
- Effect of Oral Beta Interferon on Subsequent Immune ResponsivenessAnnals of the New York Academy of Sciences, 1996
- Cytokine‐dependent Modulation of Oral Tolerance in a Murine Model of Autoimmune UveitisAnnals of the New York Academy of Sciences, 1996
- Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy?Immunology Today, 1995
- Oral administration of acetylcholine receptor: Effects on experimental myasthenia gravisAnnals of Neurology, 1994
- Binding of monomeric immunoglobulins by bone marrow‐derived mononuclear phagocytes; its modulation by interferon‐γEuropean Journal of Immunology, 1990
- γ-Interferon is one of several direct B cell-maturing lymphokinesNature, 1984